Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gp41 subunit is a transmembrane glycoprotein that forms part of the HIV-1 envelope (Env) complex, which is essential for viral entry into host cells. Gp41 mediates fusion between the viral envelope and host cell plasma membrane—a critical step for HIV entry. It contains key domains such as the fusion peptide, heptad repeats (HR1/NHR and HR2/CHR), the loop region, the membrane proximal external region (MPER), and the transmembrane domain. Its role as mediator of virus-cell fusion makes it indispensable for infection, and its conserved domains—especially MPER—are targets for vaccine design and therapeutic intervention.
Inhibition of gp41-mediated fusion by blocking heptad repeat interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycoprotein 41 subunit (gp41), HIV type I envelope (gp41).